Close Menu

Gastrointestinal

News on in vitro diagnostics for gastrointestinal disease.

The device is intended for preparation of stool samples and use with Buhlmann's Fcal Turbo calprotectin test.

Progenity gains 137 granted patents and 15 pending applications in the US, Europe, China, and Japan in the deal. 

A jury last week determined Quest did not steal trade secrets from Cedars-Sinai or breach its contract with the hospital in developing a serological IBS test.

The San Francisco-based microbial genomics firm will sell off its product lines, testing labs, IP, and data within the next three months.

The test uses turbidimetry to measure levels of fecal calprotectin, a neutrophilic protein biomarker of intestinal mucosal inflammation.